Cargando…
Allergic patients during the COVID‐19 pandemic—Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey
BACKGROUND: The COVID‐19 pandemic has affected health care systems unexpectedly. However, data focusing on practical considerations experienced by health care professionals (HCPs) providing care to allergic patients is scarce. METHODS: Under the framework of the European Academy of Allergy and Clini...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762981/ https://www.ncbi.nlm.nih.gov/pubmed/35070270 http://dx.doi.org/10.1002/clt2.12097 |
_version_ | 1784633860511760384 |
---|---|
author | Alvaro‐Lozano, Montserrat Sandoval‐Ruballos, Mónica Giovannini, Mattia Jensen‐Jarolim, Erika Sahiner, Umit Tomic Spiric, Vesna Quecchia, Cristina Chaker, Adam Heffler, Enrico Klimek, Ludger Brough, Helen Sturm, Gunter Untersmayr, Eva Bonini, Mateo Pfaar, Oliver |
author_facet | Alvaro‐Lozano, Montserrat Sandoval‐Ruballos, Mónica Giovannini, Mattia Jensen‐Jarolim, Erika Sahiner, Umit Tomic Spiric, Vesna Quecchia, Cristina Chaker, Adam Heffler, Enrico Klimek, Ludger Brough, Helen Sturm, Gunter Untersmayr, Eva Bonini, Mateo Pfaar, Oliver |
author_sort | Alvaro‐Lozano, Montserrat |
collection | PubMed |
description | BACKGROUND: The COVID‐19 pandemic has affected health care systems unexpectedly. However, data focusing on practical considerations experienced by health care professionals (HCPs) providing care to allergic patients is scarce. METHODS: Under the framework of the European Academy of Allergy and Clinical Immunology (EAACI), a panel of experts in the field of immunotherapy developed a 42‐question online survey, to evaluate real‐life consequences of the COVID‐19 pandemic in allergy practice. RESULTS: The respondents in the survey were 618. About 80% of HCPs indicated being significantly affected in their allergy practice. A face‐to‐face visit reduction was reported by 93% of HCPs and about a quarter completely interrupted diagnostic challenges. Patients with severe uncontrolled asthma (59%) and anaphylaxis (47%) were prioritized for in‐person care. About 81% maintained an unaltered prescription of inhaled corticosteroids (ICS) in asthmatics. About 90% did not modify intranasal corticosteroids (INCS) in patients with allergic rhinitis. Nearly half of respondents kept biological prescriptions unmodified for asthma. About 50% of respondents kept their allergen immunotherapy (AIT) prescription patterns unchanged for respiratory allergies; 60% for insect venom allergies. Oral immunotherapy (OIT) for food allergies was initiated by 27%. About 20% kept carrying out up‐dosing without modifications and 14% changed to more prolonged intervals. Telemedicine practice was increased. CONCLUSIONS: HCPs providing care to allergic patients were affected during the pandemic in diagnostic, management, and therapeutic approaches, including AIT for respiratory, insect‐venom, and food allergies. Most HCPs maintained controller treatments for both asthma, and allergic rhinitis consistent with international recommendations, as well as biological agents in asthma. Remote tools are valuable in delivering allergy care. |
format | Online Article Text |
id | pubmed-8762981 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87629812022-01-21 Allergic patients during the COVID‐19 pandemic—Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey Alvaro‐Lozano, Montserrat Sandoval‐Ruballos, Mónica Giovannini, Mattia Jensen‐Jarolim, Erika Sahiner, Umit Tomic Spiric, Vesna Quecchia, Cristina Chaker, Adam Heffler, Enrico Klimek, Ludger Brough, Helen Sturm, Gunter Untersmayr, Eva Bonini, Mateo Pfaar, Oliver Clin Transl Allergy Original Article BACKGROUND: The COVID‐19 pandemic has affected health care systems unexpectedly. However, data focusing on practical considerations experienced by health care professionals (HCPs) providing care to allergic patients is scarce. METHODS: Under the framework of the European Academy of Allergy and Clinical Immunology (EAACI), a panel of experts in the field of immunotherapy developed a 42‐question online survey, to evaluate real‐life consequences of the COVID‐19 pandemic in allergy practice. RESULTS: The respondents in the survey were 618. About 80% of HCPs indicated being significantly affected in their allergy practice. A face‐to‐face visit reduction was reported by 93% of HCPs and about a quarter completely interrupted diagnostic challenges. Patients with severe uncontrolled asthma (59%) and anaphylaxis (47%) were prioritized for in‐person care. About 81% maintained an unaltered prescription of inhaled corticosteroids (ICS) in asthmatics. About 90% did not modify intranasal corticosteroids (INCS) in patients with allergic rhinitis. Nearly half of respondents kept biological prescriptions unmodified for asthma. About 50% of respondents kept their allergen immunotherapy (AIT) prescription patterns unchanged for respiratory allergies; 60% for insect venom allergies. Oral immunotherapy (OIT) for food allergies was initiated by 27%. About 20% kept carrying out up‐dosing without modifications and 14% changed to more prolonged intervals. Telemedicine practice was increased. CONCLUSIONS: HCPs providing care to allergic patients were affected during the pandemic in diagnostic, management, and therapeutic approaches, including AIT for respiratory, insect‐venom, and food allergies. Most HCPs maintained controller treatments for both asthma, and allergic rhinitis consistent with international recommendations, as well as biological agents in asthma. Remote tools are valuable in delivering allergy care. John Wiley and Sons Inc. 2022-01-17 /pmc/articles/PMC8762981/ /pubmed/35070270 http://dx.doi.org/10.1002/clt2.12097 Text en © 2022 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Alvaro‐Lozano, Montserrat Sandoval‐Ruballos, Mónica Giovannini, Mattia Jensen‐Jarolim, Erika Sahiner, Umit Tomic Spiric, Vesna Quecchia, Cristina Chaker, Adam Heffler, Enrico Klimek, Ludger Brough, Helen Sturm, Gunter Untersmayr, Eva Bonini, Mateo Pfaar, Oliver Allergic patients during the COVID‐19 pandemic—Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey |
title | Allergic patients during the COVID‐19 pandemic—Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey |
title_full | Allergic patients during the COVID‐19 pandemic—Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey |
title_fullStr | Allergic patients during the COVID‐19 pandemic—Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey |
title_full_unstemmed | Allergic patients during the COVID‐19 pandemic—Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey |
title_short | Allergic patients during the COVID‐19 pandemic—Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey |
title_sort | allergic patients during the covid‐19 pandemic—clinical practical considerations: an european academy of allergy and clinical immunology survey |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762981/ https://www.ncbi.nlm.nih.gov/pubmed/35070270 http://dx.doi.org/10.1002/clt2.12097 |
work_keys_str_mv | AT alvarolozanomontserrat allergicpatientsduringthecovid19pandemicclinicalpracticalconsiderationsaneuropeanacademyofallergyandclinicalimmunologysurvey AT sandovalruballosmonica allergicpatientsduringthecovid19pandemicclinicalpracticalconsiderationsaneuropeanacademyofallergyandclinicalimmunologysurvey AT giovanninimattia allergicpatientsduringthecovid19pandemicclinicalpracticalconsiderationsaneuropeanacademyofallergyandclinicalimmunologysurvey AT jensenjarolimerika allergicpatientsduringthecovid19pandemicclinicalpracticalconsiderationsaneuropeanacademyofallergyandclinicalimmunologysurvey AT sahinerumit allergicpatientsduringthecovid19pandemicclinicalpracticalconsiderationsaneuropeanacademyofallergyandclinicalimmunologysurvey AT tomicspiricvesna allergicpatientsduringthecovid19pandemicclinicalpracticalconsiderationsaneuropeanacademyofallergyandclinicalimmunologysurvey AT quecchiacristina allergicpatientsduringthecovid19pandemicclinicalpracticalconsiderationsaneuropeanacademyofallergyandclinicalimmunologysurvey AT chakeradam allergicpatientsduringthecovid19pandemicclinicalpracticalconsiderationsaneuropeanacademyofallergyandclinicalimmunologysurvey AT hefflerenrico allergicpatientsduringthecovid19pandemicclinicalpracticalconsiderationsaneuropeanacademyofallergyandclinicalimmunologysurvey AT klimekludger allergicpatientsduringthecovid19pandemicclinicalpracticalconsiderationsaneuropeanacademyofallergyandclinicalimmunologysurvey AT broughhelen allergicpatientsduringthecovid19pandemicclinicalpracticalconsiderationsaneuropeanacademyofallergyandclinicalimmunologysurvey AT sturmgunter allergicpatientsduringthecovid19pandemicclinicalpracticalconsiderationsaneuropeanacademyofallergyandclinicalimmunologysurvey AT untersmayreva allergicpatientsduringthecovid19pandemicclinicalpracticalconsiderationsaneuropeanacademyofallergyandclinicalimmunologysurvey AT boninimateo allergicpatientsduringthecovid19pandemicclinicalpracticalconsiderationsaneuropeanacademyofallergyandclinicalimmunologysurvey AT pfaaroliver allergicpatientsduringthecovid19pandemicclinicalpracticalconsiderationsaneuropeanacademyofallergyandclinicalimmunologysurvey |